全球基因分型市場:市場規模,份額,趨勢分析,技術(PCR,毛細管電泳,微陣列,序列,質譜),產品,應用,最終用戶,地區,細分市場預測2022~2030
市場調查報告書
商品編碼
1076684

全球基因分型市場:市場規模,份額,趨勢分析,技術(PCR,毛細管電泳,微陣列,序列,質譜),產品,應用,最終用戶,地區,細分市場預測2022~2030

Genotyping Market Size, Share & Trends Analysis Report By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 78 Pages | 商品交期: 2-10個工作天內

價格

全球基因分型市場預計在預測期內以 15.6% 的複合年增長率增長,到 2030 年將達到 465 億美元。

推動市場增長的主要因素包括遺傳性疾病患病率增加、對個性化醫療的認識和研究增加,以及基因組學研究的研發資金增加。

本報告調查全球基因分型市場並分析市場概況、市場規模和預測、趨勢、增長因素和挑戰、客戶狀況、技術、產品、應用、最終用戶和地區,以及競爭形勢等。

目錄

第一章調查方法及範圍

第2章執行摘要

第 3 章基因分型市場變量、趨勢和範圍

  • 基因分型市場體系展望
  • 滲透率和增長前景映射
  • 監管框架
  • 市場動態
  • 基因分型市場分析工具

第 4 章基因分型市場:競爭分析

  • 主要市場參與者的近期趨勢和影響分析
    • 公司/競爭分類(主要創新者、市場領導者、擴張)
    • 重大交易和戰略聯盟
  • 供應商情況
    • 主要經銷商和渠道合作夥伴名單
  • 上市公司
    • 企業市場分析
    • 競爭分析儀表板
  • 私人公司
    • 主要初創企業/技術顛覆者/創新者名單
    • 區域網絡圖

第 5 章按產品劃分的業務分析

  • 基因分型市場:按產品分類的趨勢分析
  • 設備
  • 試劑和試劑盒
  • 軟件和服務

第6章按用途分析業務

  • 基因分型市場:按應用進行趨勢分析
  • 診斷/個體化醫療
  • 藥物基因組學
  • 農業生物技術
  • 動物遺傳學
  • 其他

第7章技術業務分析

  • 基因分型市場:技術趨勢分析
  • 聚合□鏈反應
  • 毛細管電泳
  • 微陣列
  • 序列
  • 質譜
  • 其他

第 8 章最終用戶的業務分析

  • 基因分型市場:最終用戶的趨勢分析
  • 製藥和生物製藥公司
  • 診斷研究實驗室
  • 學術機構
  • 其他

第9章區域業務分析

  • 基因分型市場:區域趨勢分析

第 10 章公司簡介

  • 市場參與者的分類
  • 公司簡介
Product Code: GVR-1-68038-002-6

Genotyping Market Growth & Trends:

The global genotyping market size is expected to reach USD 46.5 billion by 2030, expanding at a CAGR of 15.6%, according to a new report by Grand View Research Inc. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.

Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.

An increase in the prevalence of diseases such as cancer, Alzheimer's disease, and Parkinson's disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer's disease.

Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.

The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.

Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers' specific demands.

Genotyping Market Report Highlights:

  • The reagents & kit segment accounted for the largest share of 61.6% in the market in 2021. This is attributed to increased demand for genetic testing, increased R&D spending, and increased genotyping testing volumes
  • PCR segment dominated the market in 2021, whereas sequencing is expected to expand at the highest CAGR during the forecast period. This is due to advantages of the technique, such as low cost per sample, reduced bias as compared to arrays, comparative analysis across samples with no reference genome
  • Pharmacogenomics is estimated to be the fastest-growing application segment during the forecast period due to increased usage of genotyping in drug development to reduce attrition of products in clinical development
  • North America accounted for the largest market share in 2021, owing to proactive government measures, high disease prevalence, technological advancements, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using The Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1 Market Summary

Chapter 3. Genotyping Market Variables, Trends & Scope

  • 3.1 Genotyping Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Rising Prevalence Of Genetic And Other Target Diseases
      • 3.4.1.2 Increasing Focus On The Development Of Targeted Drugs And Personalized Medicine
      • 3.4.1.3 Technological Advancements
      • 3.4.1.4 Increase In Funding In Genomics
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Lack Of Skilled Labor
      • 3.4.2.2 Ambiguous Reimbursement Policies
  • 3.5 Genotyping Market Analysis Tools
    • 3.5.1 Porter's Five Forces Analysis
    • 3.5.2 Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. Genotyping Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
    • 4.1.2 Major Deals And Strategic Alliances
  • 4.2 Vendor Landscape
    • 4.2.1 List Of Key Distributors And Channel Partners
    • 4.2.2 Key Company Market Share Analysis, 2021
  • 4.3 Public Companies
    • 4.3.1 Company Market Position Analysis
    • 4.3.2 Competitive Dashboard Analysis
  • 4.4 Private Companies
    • 4.4.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
    • 4.4.2 Regional Network Map

Chapter 5. Product Business Analysis

  • 5.1 Genotyping Market: Product Movement Analysis
  • 5.2 Instruments
    • 5.2.1 Instruments Market, 2018 - 2030 (USD Million)
  • 5.3 Reagents & Kits
    • 5.3.1 Reagents & Kits Market, 2018 - 2030 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & Services Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1 Genotyping Market: Application Movement Analysis
  • 6.2 Diagnostics & Personalized Medicine
    • 6.2.1 Diagnostics & Personalized Medicine Market, 2018 - 2030 (USD Million)
  • 6.3 Pharmacogenomics
    • 6.3.1 Pharmacogenomics Market, 2018 - 2030 (USD Million)
  • 6.4 Agricultural Biotechnology
    • 6.4.1 Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
  • 6.3 Animal Genetics
    • 6.3.1 Animal Genetics Market, 2018 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7. Technology Business Analysis

  • 7.1 Genotyping Market: Technology Movement Analysis
  • 7.2 Pcr
    • 7.2.1 Pcr Market, 2018 - 2030 (USD Million)
  • 7.3 Capillary Electrophoresis
    • 7.3.1 Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
  • 7.4 Microarrays
    • 7.4.1 Microarrays Market, 2018 - 2030 (USD Million)
  • 7.5 Sequencing
    • 7.5.1 Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6 Mass Spectrometry
    • 7.6.1 Mass Spectrometry Market, 2018 - 2030 (USD Million)
  • 7.7 Others
    • 7.7.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1 Genotyping Market: End-Use Movement Analysis
  • 8.2 Pharmaceutical And Biopharmaceutical Companies
    • 8.2.1 Pharmaceutical And Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 8.3 Diagnostics And Research Laboratories
    • 8.3.1 Diagnostics And Research Laboratories Market, 2018 - 2030 (USD Million)
  • 8.4 Academic Institutes
    • 8.4.1 Academic Institutes Market, 2018 - 2030 (USD Million)
  • 8.5 Others
    • 8.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1 Genotyping Market: Regional Movement Analysis
    • 9.1.1 North America
      • 9.1.1.1 North America Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.1.2 U.S.
      • 9.1.1.2.1 U.S. Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.1.3 Canada
      • 9.1.1.3.1 Canada Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.2 Europe
      • 9.1.2.1 Europe Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.2 Uk
      • 9.1.2.2.1 Uk Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.3 Germany
      • 9.1.2.3.1 Germany Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.4 France
      • 9.1.2.4.1 France Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.5 Spain
      • 9.1.2.5.1 Spain Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.2.6 Italy
      • 9.1.2.6.1 Italy Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.3 Asia Pacific
      • 9.1.3.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.2 Japan
      • 9.1.3.2.1 Japan Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.3 China
      • 9.1.3.3.1 China Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.4 India
      • 9.1.3.4.1 India Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.5 Australia
      • 9.1.3.5.1 Australia Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.3.6 South Korea
      • 9.1.3.6.1 South Korea Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.4 Latin America
      • 9.1.4.1 Latin America Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.2 Brazil
      • 9.1.4.2.1 Brazil Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.3 Mexico
      • 9.1.4.3.1 Mexico Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.4.4 Argentina
      • 9.1.4.4.1 Argentina Market Estimates And Forecast, 2018 - 2030, USD Million
    • 9.1.5 Middle East & Africa
      • 9.1.5.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.2 South Africa
      • 9.1.5.2.1 South Africa Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.3 Saudi Arabia
      • 9.1.5.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030, USD Million
      • 9.1.5.5 United Arab Emirates
      • 9.1.5.5.1 United Arab Emirates Market Estimates And Forecast, 2018 - 2030, USD Million

Chapter 10. Company Profile

  • 10.1 Market Participation Categorization
  • 10.2 Company Profiles
    • 10.2.1 Illumina Inc.
      • 10.2.1.1 Company Overview
      • 10.2.1.3 Financial Performance
      • 10.2.1.4 Product Benchmarking
      • 10.2.1.5 Strategic Initiatives
    • 10.2.2 Thermo Fisher Scientific Inc.
      • 10.2.2.1 Company Overview
      • 10.2.2.2 Financial Performance
      • 10.2.2.3 Product Benchmarking
      • 10.2.2.4 Strategic Initiatives
    • 10.2.3 Qiagen Inc.
      • 10.2.3.1 Company Overview
      • 10.2.3.2 Financial Performance
      • 10.2.3.3 Product Benchmarking
      • 10.2.3.4 Strategic Initiatives
    • 10.2.4 F. Hoffman-La Roche Ltd.
      • 10.2.4.1 Company Overview
      • 10.2.4.2 Financial Performance
      • 10.2.4.3 Product Benchmarking
      • 10.2.4.4 Strategic Initiatives
    • 10.2.5 Fluidigm Corporation
      • 10.2.5.1 Company Overview
      • 10.2.5.2 Financial Performance
      • 10.2.5.3 Product Benchmarking
      • 10.2.5.4 Strategic Initiatives
    • 10.2.6 Danaher Corporation
      • 10.2.5.1 Company Overview
      • 10.2.5.2 Financial Performance
      • 10.2.5.3 Product Benchmarking
      • 10.2.5.4 Strategic Initiatives
    • 10.2.7 Agilent Technologies
      • 10.2.7.1 Company Overview
      • 10.2.7.2 Financial Performance
      • 10.2.7.3 Product Benchmarking
      • 10.2.7.4 Strategic Initiatives
    • 10.2.8 Eurofins Scientific Inc.
      • 10.2.8.1 Company Overview
      • 10.2.8.2 Financial Performance
      • 10.2.8.3 Product Benchmarking
      • 10.2.8.4 Strategic Initiatives
    • 10.2.9 Ge Healthcare Inc.
      • 10.2.9.1 Company Overview
      • 10.2.9.2 Financial Performance
      • 10.2.9.3 Product Benchmarking
      • 10.2.9.4 Strategic Initiatives
    • 10.2.10 Bio-Rad Laboratories Inc.
      • 10.2.10.1 Company Overview
      • 10.2.10.2 Financial Performance
      • 10.2.10.3 Product Benchmarking
      • 10.2.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 4 North America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20 UK genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21 UK genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 22 UK genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 26 Germany genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 27 France genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28 France genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 France genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 30 France genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Italy genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32 Italy genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 34 Italy genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 38 Spain genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Japan genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 44 Japan genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 45 Japan genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 46 Japan genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 China genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 China genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 50 China genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 52 India genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 India genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 54 India genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Australia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 56 Australia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 57 Australia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 62 South Korea genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 66 Latin America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68 Brazil genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 70 Brazil genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Mexico genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 72 Mexico genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 Mexico genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 74 Mexico genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Argentina genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 Argentina genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 80 MEA genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 81 MEA genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 82 MEA genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 8 South Africa genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 82 South Africa genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 83 South Africa genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 90 UAE genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 93 UAE genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 94 List of key distributors

List of Figures

  • Fig. 1 Genotyping market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Genotyping market snapshot
  • Fig. 10 Genotyping market driver impact
  • Fig. 11 Genotyping market restraint impact
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal economic, and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Genotyping market: Product movement analysis
  • Fig. 16 Genotyping product outlook: Key takeaways
  • Fig. 17 Instruments market, 2018 - 2030 (USD million)
  • Fig. 18 Reagents & Kits market, 2018 - 2030 (USD million)
  • Fig. 19 Software & Services market, 2018 - 2030 (USD million)
  • Fig. 20 Genotyping market: Technology movement analysis
  • Fig. 21 Genotyping technology outlook: Key takeaways
  • Fig. 22 PCR market, 2018 - 2030 (USD million)
  • Fig. 23 Capillary Electrophoresis market, 2018 - 2030 (USD million)
  • Fig. 24 Microarrays market, 2018 - 2030 (USD million)
  • Fig. 25 Mass Spectrometry market, 2018 - 2030 (USD million)
  • Fig. 26 Others market, 2018 - 2030 (USD million)
  • Fig. 27 Genotyping market: Application movement analysis
  • Fig. 28 Genotyping application outlook: Key takeaways
  • Fig. 29 Diagnostics & personalized medicine market, 2018 - 2030 (USD million)
  • Fig. 30 Pharmacogenomics market, 2018 - 2030 (USD million)
  • Fig. 31 Agricultural biotechnology market, 2018 - 2030 (USD million)
  • Fig. 32 Animal genetics market, 2018 - 2030 (USD million)
  • Fig. 33 Others market, 2018 - 2030 (USD million)
  • Fig. 34 Genotyping market: End-use movement analysis
  • Fig. 35 Genotyping end-use outlook: Key takeaways
  • Fig. 36 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD million)
  • Fig. 37 Diagnostics and research laboratories market, 2018 - 2030 (USD million)
  • Fig. 38 Academic institutes market, 2018 - 2030 (USD million)
  • Fig. 39 Others market, 2018 - 2030 (USD million)
  • Fig. 40 Genotyping market: Regional outlook and key takeaways
  • Fig. 41 Genotyping market: Regional movement analysis
  • Fig. 42 North America
  • Fig. 43 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 U.S.
  • Fig. 45 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Canada
  • Fig. 47 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Europe
  • Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 UK
  • Fig. 51 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Germany
  • Fig. 53 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy
  • Fig. 55 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain
  • Fig. 57 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 France
  • Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Japan
  • Fig. 63 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 China
  • Fig. 65 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 India
  • Fig. 67 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Australia
  • Fig. 69 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America
  • Fig. 73 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil
  • Fig. 75 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Mexico
  • Fig. 77 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina
  • Fig. 79 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Middle East & Africa
  • Fig. 81 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa
  • Fig. 83 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 UAE
  • Fig. 87 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG.88 Company market share analysis
  • FIG.89 Company market position analysis (Revenue US$ mn)
  • FIG.90 Company market position analysis (Profit Margin)
  • Fig. 91Competitive dashboard analysis
  • Fig. 92 Regional Network Map